Subacute Cutaneous Lupus Erythematosus Associated with Hydrochlorothiazide Therapy

  1. BARBARA R. REED, M.D.;
  2. J. CLARK HUFF, M.D.;
  3. STEPHEN K. JONES, M.D.;
  4. PAUL W. ORTON, M.D.;
  5. LELA A. LEE, M.D.; and
  6. DAVID A. NORRIS, M.D.
  1. Denver, Colorado

    Abstract

    Photosensitive eruptions with clinical and histologic features of subacute cutaneous lupus erythematosus and antibodies to SS-A(Ro) antigen occurred in five patients taking hydrochlorothiazide. After drug therapy was discontinued, the eruptions cleared. In one patient anti-SS-A antibodies disappeared after discontinuation of thiazide, and in another rechallenge with hydrochlorothiazide produced an acute dermatitis with a photodistribution. These eruptions may represent a new type of photosensitive drug reaction in which the photoactive drug may be synergistic with anti-SS-A antibody in producing cutaneous lesions of photosensitive subacute cutaneous lupus erythematosus.

    Article and Author Information

    • ▸From the Department of Dermatology, University of Colorado Health Sciences Center; Denver, Colorado.

    • ▸Requests for reprints should be addressed to David A. Norris, M.D.; Department of Dermatology, Box B-153, University of Colorado School of Medicine, 4200 East Ninth Street; Denver, CO 80262.

    « Previous | Next Article »Table of Contents